
On Aug. 16, Hussain will step into the role of CEO at Vifor Pharma after Stefan Schulze has opted to resign for personal reasons, according to a Vifor Pharma press release.
Like the Danish company Pharmacosmos, Vifor Pharma focuses on iron deficiency, among other expertise areas.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app